Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2010 Apr;17(4):539-40.
doi: 10.1016/j.jocn.2009.09.001. Epub 2010 Feb 19.

Impulsive smoking in a patient with Parkinson's disease treated with dopamine agonists

Affiliations
Case Reports

Impulsive smoking in a patient with Parkinson's disease treated with dopamine agonists

Karina L Bienfait et al. J Clin Neurosci. 2010 Apr.

Abstract

Impulse control disorders, including pathological gambling, binge eating, compulsive shopping and hypersexual behaviors, have frequently been reported as a side effect of dopaminergic medications for Parkinson's disease (PD). Here we describe a patient with PD who developed an unusual manifestation of impulsive behaviors, including cigarette smoking, associated with an increase in dopamine agonist medication. We postulate this to be related to an overstimulation of mesolimbic dopamine receptors responsible for reward-seeking behaviors. Further research is needed to examine impulsive cigarette smoking in PD.

PubMed Disclaimer

References

    1. Wolters E, van der Werf Y, van den Heuvel O. Parkinson’s disease-related disorders in the impulsive-compulsive spectrum. J Neurol. 2008;255:48–56. - PubMed
    1. Voon V, Potenza MN, Thomsen T. Medication-related impulse control and repetitive behaviors in Parkinson’s disease. Curr Opin Neurol. 2007;20:484–492. - PubMed
    1. Lim SY, Evans AH, Miyasaki JM. Impulse control and related disorders in Parkinson’s disease. Ann NY Acad Sci. 2008;1142:85–107. - PubMed
    1. Weintraub D, Siderowf AD, Potenza MN, et al. Association of dopamine agonist use with impulse conrol disorders in Parkinson’s disease. Arch Neurol. 2006;63:969–973. - PMC - PubMed
    1. Weintraub D, Koester J, Potenza MN, et al. Dopaminergic therapy and impulse control disorders in Parkinson’s disease: A cross-sectional study of over 3,000 patients. Presented at the Movement Disorder Society Congress of Parkinson’s disease and Movement Disorders; June 25, 2008.

Publication types

MeSH terms